Skip to content

Trial of Acupuncture in the Treatment of Fibromyalgia

Pragmatic Randomized Controlled Trial of Acupuncture Effectiveness in the Treatment of Fibromyalgia

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01189994
Enrollment
60
Registered
2010-08-27
Start date
2010-09-30
Completion date
2011-12-31
Last updated
2010-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diffuse Myofascial Pain Syndrome, Fibromyalgia, Fibromyalgia-Fibromyositis Syndrome, Fibromyositis-Fibromyalgia Syndrome, Myofascial Pain Syndrome, Diffuse

Keywords

Fibromyalgia, Acupuncture, Randomized Controlled Trial, Pain, Quality of Life

Brief summary

Fibromyalgia is a medical condition characterized by musculoskeletal pain, fatigue, sleep disturbances and depression. It affects population at a socioeconomically active age and represents a burden for the patients and the health care system due to its personal and functional implications. At this moment, there is no completely effective treatment for fibromyalgia, and acupuncture has been a promising alternative. This trial aims to evaluate if addition of acupuncture to standard care represents an improvement in comparison with standard care only. Thus, patients enrolled in this trial will be randomly allocated into one of two groups: group A, who besides standard treatment will receive 12 sessions of acupuncture; and group B, who will receive standard care with monthly orientation sessions for the same period. Patients will be evaluated at baseline, after completion of acupuncture treatment or orientation, and after an additional 12-week follow up. Evaluation will be based on diaries of pain and medication, and standard scales of pain, quality of life and disability.

Interventions

PROCEDUREAcupuncture

Needling of acupoints, some of them receiving electrostimulation

BEHAVIORALOrientation

Orientation sessions focusing in fibromyalgia

Sponsors

Santa Casa da Misericordia do Rio de Janeiro Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* American College of Rheumatology criteria for fibromyalgia * elementary school * drug treatment for at least 30 days (if any)

Exclusion criteria

* disabling mental condition * other rheumatic conditions * other chronic medical conditions with musculoskeletal symptoms * pregnancy * conditions that impair walking * conditions that impair weekly consultations * acupuncture treatment in the twelve-month period prior to enrollment * diabetes mellitus

Design outcomes

Primary

MeasureTime frame
Fibromyalgia Impact Questionnaire (FIQ) scoreTwelve weeks from baseline

Secondary

MeasureTime frame
Visual Analog Scale (VAS) for painTwelve weeks from baseline
Short Form 36 (SF-36) score for quality of lifeTwelve weeks from baseline
Weekly Likert scale in pain diaryTwelve weeks from baseline
Hospital Anxiety and Depression (HAD) ScaleTwelve weeks from baseline
Fibromyalgia Impact Questionnaire (FIQ) scoreTwenty-four weeks from baseline
Health Assessment Questionnaire - Disability Index (HAQ-DI) scoreTwelve weeks from baseline

Countries

Brazil

Contacts

Primary ContactFernando P de Farias, MD, PhD
fernandopfarias@gmail.com(+5521) 9263-8673

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026